Sociedad Americana de Hirudoterapia

Rediscovered historical lots uncover the identity of Nikolaj A. Livanow's Protoclepsis species and clarify the taxonomy of Palearctic waterfowl-associated leeches

Research article published in Syst Parasitol (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Ensayos clínicosSeguridad y control de infeccionesBolotov IN et al. · Syst Parasitol, 2025

Abstract

In 1902, Nikolaj Livanow described a new genus, Protoclepsis, together with three new nominal species: P. meyeri, P. garjaewi, and P. tessellatoides. The syntypes of the first species were collected in Kazan (European Russia), while those of the two latter species were obtained from Lake Baikal (Siberia). The genus Protoclepsis Livanow, 1902 was established for a group of waterfowl-associated leeches with four pairs of eyespots and represents a synonym of Theromyzon Philippi, 1867. In contrast, the taxonomic concept of Livanow's nominal species was a matter of over a century-long discussion. Here, we revise the taxonomic position of these taxa based upon morphological examination of the original type series that were rediscovered in the Edward Eversman Zoology Museum and Herbarium, Kazan (Volga Region) Federal University, Russia. The lectotype is designated for each of the three nominal species. We found that Protoclepsis garjaewi morphologically corresponds to Hyperboreomyzon polaris Bolotov et al., 2022, although the first taxon was incorrectly described by Livanow as having four pairs of eyespots. Hence, Hyperboreomyzon garjaewi (Livanow, 1902) comb. nov. is proposed. Protoclepsis meyeri represents a synonym of Theromyzon maculosum (Rathke, 1862), as suggested by Livanow himself, while Protoclepsis tessellatoides is a synonym of Theromyzon mollissimum (Grube, 1871). Protoclepsis mollissima Livanow, 1902 incertae sedis has strongly reduced papillation and pigmentation and is tentatively considered a deep-water ecological race of Theromyzon mollissimum. A key for reliable morphological identification of the waterfowl-associated glossiphoniid leeches of Northern Eurasia is also presented. Our findings highlight the low level of endemism of glossiphoniid leeches in Lake Baikal.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsLeechesSpecies SpecificityRussia

Resumen

Taxonomic revision of Protoclepsis species based on Livanow's rediscovered syntypes; Hyperboreomyzon garjaewi comb.

Por qué esto importa para la hirudoterapia

This study examined the historical type series of waterfowl-associated leeches to clarify the taxonomic confusion surrounding the genus Protoclepsis, described by Nikolaj Livanow in 1902. Through morphological examination, researchers synonymized several nominal species under the genus Theromyzon and provided a key for identifying glossiphoniid leeches in Northern Eurasia. Accurate taxonomic classification and species identification are essential for biological research, ensuring that scientists and clinicians correctly identify leech species with potential biomedical utility. This article is strictly a taxonomic revision of non-medicinal, waterfowl-associated leeches and provides no direct clinical data or applications for hirudotherapy.

Citación

Rediscovered historical lots uncover the identity of Nikolaj A. Livanow's Protoclepsis species and clarify the taxonomy of Palearctic waterfowl-associated leeches.

Bolotov IN et al. · Syst Parasitol, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.